Clinical Trial Update: Extended-release Sodium Oxybate in Children [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating an extended-release formulation of sodium oxybate in children with Narcolepsy Type 1 is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy Type

Drugs mentioned

• Extended-release sodium oxybate (sodium oxybate (extended-release formulation))

Snippet

Sponsor: Stanford University | Conditions: Narcolepsy Type 1 (NT 1) | Phase 2 | Status: RECRUITING